Testicular cancer

The Urology Care Foundation Encourages Men to Take Charge of Their Health, One Checkup at A Time, For Men’s Health Month

Retrieved on: 
Freitag, Mai 31, 2024

BALTIMORE, May 31, 2024 (GLOBE NEWSWIRE) -- June starts Men’s Health Month, and the Urology Care Foundation, the official foundation of the American Urological Association (AUA), is encouraging men to take charge of their health, one checkup at a time.

Key Points: 
  • BALTIMORE, May 31, 2024 (GLOBE NEWSWIRE) -- June starts Men’s Health Month, and the Urology Care Foundation, the official foundation of the American Urological Association (AUA), is encouraging men to take charge of their health, one checkup at a time.
  • But cancers are not the only urological issues men should be getting checked out; for men, urology includes the entire urinary tract and reproductive organs.
  • Once these problems are diagnosed, men can partner with a men's health specialist to get things back on the right track.
  • For more information on all aspects of men’s health, view the Urology Care Foundation’s Men’s Health Month Info Center.

SAXX, 'Ball Masters' Begin Second Round: Men's Underwear Brand Inks Deal with Fifth Pro Caddie, Announces Search for Honorary Members

Retrieved on: 
Dienstag, April 16, 2024

VANCOUVER, BC, April 16, 2024 /PRNewswire/ -- The Ball Masters are back and better than ever.

Key Points: 
  • "It's impossible to ignore the connection between how SAXX underwear and caddies care for balls.
  • But the best part of this partnership is showcasing the hidden heroes that support golfers – just like the BallPark Pouch™ supports men."
  • Fans can rest easy knowing their favorite caddies are comfortably supported as they rake bunkers, read putts and check wind directions this season.
  • SAXX is the OG pouch underwear brand and inventors of the BallPark Pouch™ , so they know a thing or two about men's balls.

Family Source Consultants Partners with Worth the Wait Charity to Support Young Adult Cancer Patients & Survivors Pursuing Parenthood

Retrieved on: 
Donnerstag, April 11, 2024

CHICAGO, April 10, 2024 /PRNewswire-PRWeb/ -- This coming September, leading surrogacy agency Family Source Consultants (FSC) will serve as a main sponsor for a fundraising event in support of Worth the Wait Charity. The non-profit organization is dedicated to assisting young adult cancer patients and survivors start their family, many of whom struggle with infertility following treatment. Worth the Wait Charity provides grants to help offset the costs of building families through fertility preservation, adoption, fertility treatments and surrogacy.

Key Points: 
  • This support will make a world of difference in helping ease the financial burden for young adult cancer survivors pursuing parenthood.
  • All proceeds from Jeep Off Cancer will directly support Worth the Wait Charity's mission of aiding young adult cancer patients and survivors on their journey to parenthood.
  • This support will make a world of difference in helping ease the financial burden for young adult cancer survivors pursuing parenthood."
  • "Family Source Consultants couldn't be more eager to support Worth the Wait Charity's Jeep Off Cancer event," said Swiderski.

U.S. adults are still behind on routine cancer screenings—but reasons why vary by race

Retrieved on: 
Dienstag, April 2, 2024

The survey revealed that nearly seven in 10 U.S. adults are behind on at least one routine cancer screening.1

Key Points: 
  • The survey revealed that nearly seven in 10 U.S. adults are behind on at least one routine cancer screening.1
    The second annual survey, released during Cancer Prevention and Early Detection Month in April, indicates more U.S. adults are behind on routine cancer screenings compared to last year.
  • It is crucial to advocate for your health and talk to your health care provider about the routine cancer screenings you need.
  • “We are reaffirming our commitment to empowering people to stay ahead of cancer through prevention and early detection until all populations can achieve better outcomes—without any barriers to the process.”
    1The cancer screenings studied in this survey were for breast cancer, cervical cancer, colorectal cancer, lung cancer, oral cancer, prostate cancer, skin cancer and testicular cancer.
  • 2In this survey, Gen Z is defined as adults ages 21-27 and Millennials are defined as adults ages 28-43.

Don’t Drop the Ball! The Urology Care Foundation Urges Men to Check Themselves for Testicular Cancer Awareness Month

Retrieved on: 
Montag, April 1, 2024

BALTIMORE, April 01, 2024 (GLOBE NEWSWIRE) -- April is Testicular Cancer Awareness Month, and the Urology Care Foundation, the official foundation of the American Urological Association (AUA), is urging men not to drop the ball when it comes to their testicular health.

Key Points: 
  • BALTIMORE, April 01, 2024 (GLOBE NEWSWIRE) -- April is Testicular Cancer Awareness Month, and the Urology Care Foundation, the official foundation of the American Urological Association (AUA), is urging men not to drop the ball when it comes to their testicular health.
  • Testicular cancer is one of the less common cancers in men, with only 1 out of every 250 men getting diagnosed during their lifetime.
  • The best way to increase the chances we can cure someone of testicular cancer is to catch it early.
  • Prostate exams, scrotal exams, penis stuff, all of it,” said C. Freeman McCluskey, MD, testicular cancer survivor and urology resident at the Medical College of Georgia.

Hearing loss company Acousia announces first patient enrolled in its Phase 2 PROHEAR-Study

Retrieved on: 
Donnerstag, Februar 15, 2024

TÜBINGEN, Germany, Feb. 15, 2024 /PRNewswire/ -- Acousia Therapeutics GmbH, a Tübingen-based clinical stage biotech company focused on the enhancement and preservation of natural hearing, just announced the randomization of the first patient for the PROHEAR-Study.

Key Points: 
  • TÜBINGEN, Germany, Feb. 15, 2024 /PRNewswire/ -- Acousia Therapeutics GmbH, a Tübingen-based clinical stage biotech company focused on the enhancement and preservation of natural hearing, just announced the randomization of the first patient for the PROHEAR-Study.
  • Germ-cell testicular cancer is the most common cancer among young men, with incidence rates continuously increasing.
  • In preclinical models, ACOU085 has demonstrated its significant potential to reduce cisplatin-induced hearing loss and preserve outer hair cells from ototoxicity.
  • "The enrollment of the first patient into our ACOU085 Clinical Phase 2 program marks a further major milestone in our efforts to finally make acute and subacute forms of hearing loss treatable" said Dr. Tim Bölke, CEO and CMO of Acousia Therapeutics.

Hearing loss company Acousia announces first patient enrolled in its Phase 2 PROHEAR-Study

Retrieved on: 
Donnerstag, Februar 15, 2024

TÜBINGEN, Germany, Feb. 15, 2024 /PRNewswire/ -- Acousia Therapeutics GmbH, a Tübingen-based clinical stage biotech company focused on the enhancement and preservation of natural hearing, just announced the randomization of the first patient for the PROHEAR-Study.

Key Points: 
  • TÜBINGEN, Germany, Feb. 15, 2024 /PRNewswire/ -- Acousia Therapeutics GmbH, a Tübingen-based clinical stage biotech company focused on the enhancement and preservation of natural hearing, just announced the randomization of the first patient for the PROHEAR-Study.
  • Germ-cell testicular cancer is the most common cancer among young men, with incidence rates continuously increasing.
  • In preclinical models, ACOU085 has demonstrated its significant potential to reduce cisplatin-induced hearing loss and preserve outer hair cells from ototoxicity.
  • "The enrollment of the first patient into our ACOU085 Clinical Phase 2 program marks a further major milestone in our efforts to finally make acute and subacute forms of hearing loss treatable" said Dr. Tim Bölke, CEO and CMO of Acousia Therapeutics.

Urology Care Foundation Spreads Awareness for National Cancer Prevention Month

Retrieved on: 
Mittwoch, Januar 31, 2024

BALTIMORE, Jan. 31, 2024 (GLOBE NEWSWIRE) -- February is National Cancer Prevention Month, and the Urology Care Foundation, the official foundation of the American Urological Association (AUA), wants to spread awareness and information on the six main urologic cancers.

Key Points: 
  • BALTIMORE, Jan. 31, 2024 (GLOBE NEWSWIRE) -- February is National Cancer Prevention Month, and the Urology Care Foundation, the official foundation of the American Urological Association (AUA), wants to spread awareness and information on the six main urologic cancers.
  • However, there are other urologic cancers that involve the bladder, kidneys and testicles,” said Urology Care Foundation Board of Directors member Brian McNeil, MD, MBA, FACS.
  • The Urology Care Foundation believes the first part of prevention is education.
  • Below are the six main urologic cancers and important resources for each:
    Bladder Cancer is the second most common type of urologic cancer.

Confusion about insurance coverage for cervical cancer screenings contributes to missed screening

Retrieved on: 
Mittwoch, Januar 3, 2024

The 2023 survey shows 41% of American women are not up to date on cervical cancer screenings.2 This indicates an urgent need to discuss the cost of cervical cancer screening, as many people may be unaware cervical cancer screenings are covered through Medicaid and most private insurance plans.

Key Points: 
  • The 2023 survey shows 41% of American women are not up to date on cervical cancer screenings.2 This indicates an urgent need to discuss the cost of cervical cancer screening, as many people may be unaware cervical cancer screenings are covered through Medicaid and most private insurance plans.
  • That means, under current law, if you have health insurance and you have a cervix, your cervical cancer screenings are covered.
  • The elimination of cervical cancer will be severely hindered without proper education across all populations about screening, insurance coverage and HPV vaccination.
  • 2The cancer screenings studied in this survey were for breast cancer, cervical cancer, colorectal cancer, oral cancer, lung cancer, prostate cancer, skin cancer and testicular cancer.

NordVPN partners with Movember and doubles donations

Retrieved on: 
Freitag, Dezember 22, 2023

LONDON, Dec. 22, 2023 /PRNewswire/ -- NordVPN, a leading cybersecurity company, is proud to announce its partnership with Movember, a global movement committed to changing the face of men's health. Up until August 31, 2024, NordVPN will be supporting Movember's mission to raise awareness and contribute to the important cause of men's mental health and well-being. For some time NordVPN will also be doubling donations.

Key Points: 
  • Up until August 31, 2024, NordVPN will be supporting Movember's mission to raise awareness and contribute to the important cause of men's mental health and well-being.
  • For some time NordVPN will also be doubling donations .
  • Movember, renowned for its iconic moustache-growing campaign, focuses on addressing key issues affecting men, including mental health, suicide prevention, prostate cancer, and testicular cancer.
  • "We are excited to join forces with Movember to shed light on crucial issues that impact men's lives," said Bob Brinklow, country manager for the UK at NordVPN .